EMD-9588

Single-particle
3.6 Å
EMD-9588
3D View Gallery
Deposition: 26/07/2018
Map released: 08/08/2018
Last modified: 06/11/2019
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-9588
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 6acc summary report (pdf.gz) Map and 6acc FULL report (pdf.gz)
EMICSS annotations (xml)

Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conformation with three RBD in down conformation

EMD-9588

Single-particle
3.6 Å
EMD-9588
3D View Gallery
Deposition: 26/07/2018
Map released: 08/08/2018
Last modified: 06/11/2019
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Name: Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein
Complex [1]
Name: Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein
Natural source [1]
Organism: SARS coronavirus
Recombinant Expression [1]
Organism Strain Cell Plasmid
Spodoptera frugiperda - - -
Molecular weight
Experimental Theoretical Method
- 400 kDa -
Complex Portal [2]
ID Name Overlap
CPX-7088 SARS-CoV uncleaved Spike protein complex 1.00
CPX-5694 SARS-CoV cleaved Spike protein complex 1.00
Protein [1]
LEVO
Name: Spike glycoprotein
Number of copies: 3
UniProtKB PDBe-KB
Domains
Gene Ontology [8]
Biological process:
fusion of virus membrane with host plasma membrane endocytosis involved in viral entry into host cell receptor-mediated virion attachment to host cell fusion of virus membrane with host endosome membrane

Cellular location:
membrane virion membrane viral envelope integral component of membrane
Natural source
Organism: Human SARS coronavirus
Molecular weight
Experimental Theoretical Method
- 133 kDa -
Recombinant Expression
Organism Strain Cell Plasmid
Spodoptera frugiperda - - -